198 results
8-K
EX-99.2
ALKS
Alkermes plc
24 Jul 24
Alkermes plc Reports Second Quarter 2024 Financial Results
7:05am
$ --- Research and development 3.9 Selling, general and administrative --- Income tax benefit $ (0.6) Loss from discontinued operations, net of tax $ 3.3 … (In millions) Year Ended December 31, 2023 Three Months Ended June 30, 2023 Cost of goods manufactured and sold $ 0.0 Research and development 32.6 Selling
8-K
EX-99.1
ALKS
Alkermes plc
24 Jul 24
Alkermes plc Reports Second Quarter 2024 Financial Results
7:05am
in development for neurological disorders, including narcolepsy. Headquartered in Ireland, Alkermes also has a corporate office and research and development … and development revenue
Total Revenues
Expenses:
Cost of goods manufactured and sold
Research and development
Selling, general and administrative
Amortization
8-K
EX-99.2
ALKS
Alkermes plc
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
Operations (In thousands) Year Ended December 31, 2023 Three Months Ended March 31, 2024 Cost of goods manufactured and sold $ -- Research and development … Ended December 31, 2023 Three Months Ended March 31, 2023 Cost of goods manufactured and sold $ 11 Research and development 29,867 Selling, general
8-K
EX-99.1
5ptr ohrdwo5m
1 May 24
Alkermes plc Reports First Quarter 2024 Financial Results
7:05am
8-K
EX-99.1
axm6enl3
9 Apr 24
Regulation FD Disclosure
7:09am
8-K
EX-99.1
hz9p2f89
7 Mar 24
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7:09am
8-K
EX-99.1
vvyzn2ne47bfd2 v5
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
EX-99.2
78617u hf
15 Feb 24
Results of Operations and Financial Condition
7:05am
8-K
EX-99.1
6dmx8pjsd8m7s2hh
14 Dec 23
Alkermes plc Announces Agreement to Sell Athlone, Ireland Facility to Novo Nordisk
6:13am
8-K
EX-99.1
e6axfp0l8xqz
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
iif4vcq1qfv5xr
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-10.1
i3nv e06x44h7zhwb
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am